GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Feng Chi Biotech Corp (ROCO:6744) » Definitions » Gross Margin %

Feng Chi Biotech (ROCO:6744) Gross Margin % : 45.03% (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Feng Chi Biotech Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Feng Chi Biotech's Gross Profit for the six months ended in Dec. 2023 was NT$38.8 Mil. Feng Chi Biotech's Revenue for the six months ended in Dec. 2023 was NT$86.2 Mil. Therefore, Feng Chi Biotech's Gross Margin % for the quarter that ended in Dec. 2023 was 45.03%.


The historical rank and industry rank for Feng Chi Biotech's Gross Margin % or its related term are showing as below:

ROCO:6744' s Gross Margin % Range Over the Past 10 Years
Min: 41.44   Med: 45.9   Max: 49.28
Current: 44.7


During the past 8 years, the highest Gross Margin % of Feng Chi Biotech was 49.28%. The lowest was 41.44%. And the median was 45.90%.

ROCO:6744's Gross Margin % is ranked worse than
67.07% of 750 companies
in the Biotechnology industry
Industry Median: 60.88 vs ROCO:6744: 44.70

Feng Chi Biotech had a gross margin of 45.03% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Feng Chi Biotech was -0.50% per year.


Feng Chi Biotech Gross Margin % Historical Data

The historical data trend for Feng Chi Biotech's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Feng Chi Biotech Gross Margin % Chart

Feng Chi Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial 41.44 48.03 47.16 43.13 44.70

Feng Chi Biotech Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.31 41.56 44.97 44.40 45.03

Competitive Comparison of Feng Chi Biotech's Gross Margin %

For the Biotechnology subindustry, Feng Chi Biotech's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Feng Chi Biotech's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Feng Chi Biotech's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Feng Chi Biotech's Gross Margin % falls into.



Feng Chi Biotech Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Feng Chi Biotech's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=80.7 / 180.578
=(Revenue - Cost of Goods Sold) / Revenue
=(180.578 - 99.857) / 180.578
=44.70 %

Feng Chi Biotech's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=38.8 / 86.225
=(Revenue - Cost of Goods Sold) / Revenue
=(86.225 - 47.4) / 86.225
=45.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Feng Chi Biotech  (ROCO:6744) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Feng Chi Biotech had a gross margin of 45.03% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Feng Chi Biotech Gross Margin % Related Terms

Thank you for viewing the detailed overview of Feng Chi Biotech's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Feng Chi Biotech (ROCO:6744) Business Description

Traded in Other Exchanges
N/A
Address
No. 5, Shaoxing North Street, 5th Floor-1, Zhongzheng District, Taipei City, TWN, 100
Feng Chi Biotech Corp provide promotion and support for clinical testing and molecular genetic medicine research related technologies. The company's products and services include clinical testing, food testing, newborn screening, prenatal screening, iron stomach, interscience, and colony counting.

Feng Chi Biotech (ROCO:6744) Headlines

No Headlines